O‘T-TOSH KASALLIGINI TASHXISLASHDA UTT (ULTRATOVUSH TEKSHIRUVI) VA MRT SAMARADORLIGINI BAHOLASH
Keywords:
Kalit so‘zlar: O‘t-tosh kasalligi; xolelitiyoz; xolesistit; mexanik sariqlik; MRCP; UZI; UTT; MRT; KT; CEUS; sezgirlik; o‘ziga xoslik; diagnostik aniqlik; tosh aniqlash; o‘t pufagi; o‘t yo‘llari; sun’iy intellekt; monitoring; invaziv bo‘lmagan diagnostikaAbstract
Annotasiya: O‘t-tosh kasalligini tashxislashda ultratovush tekshiruvi (UTT) va magnit-rezonans tomografiyasi (MRT) bugungi kunda eng ko‘p qo‘llaniladigan invaziv bo‘lmagan usullar hisoblanadi. Ikkala usul ham kasallikning o'rni, tarqalishi va faollik darajasini yuqori aniqlikda aniqlash imkonini beradi, biroq ularning diagnostik imkoniyatlari bir qator jihatlarda farqlanadi. MRT ingichka ichakdagi o'zgarishlarni aniqlashda sezgirligi va o'ziga xosligi bo'yicha UTTga nisbatan 10–14% yuqori natija ko'rsatadi. Ayniqsa fistula, striktura va ekstramuralь asoratlarni vizualizatsiya qilishda MRT aniq ustunlikka ega. Shu bilan birga, MRT qimmatligi, keng tarqalmagan ixtisoslashgan uskunalar talab etishi va tekshiruv muddatining uzunligi (taxminan 60 daqiqa) kabi cheklovlarga ega. UTT esa arzon, real vaqtda, nurlanishsiz bajarilishi va bemorlar tomonidan yaxshiroq qabul qilinishi bilan ajralib turadi. Zamonaviy kontrast moddali UTT (SICUS) esa MRTga yaqinlashuvchi aniqlikni — 95% gacha sezgirlikni — ko'rsata boshladi. Davolanish jarayonini kuzatishda, ayniqsa yosh bemorlarda, UTT birinchi tanlov usuli sifatida tobora ko'proq e'tirof etilmoqda.
References
(1) Lee D.I., You M.W., Park S.H., Seo M., Park S.J. "Comparison of Diagnostic Performance of Ultrasonography and Magnetic Resonance Enterography in the Assessment of Active Bowel Lesions in Patients with Crohn's Disease: A Systematic Review and Meta-Analysis." Diagnostics (MDPI). 2022 yil 19 avgust. Vol. 12, No. 8, Article 2008. 752 bemor. DOI: 10.3390/diagnostics12082008. PMCID: PMC9407121. Mualliflar: Koreya, Kyung Hee University Hospital va Gachon University.
(2) Puca P., Del Vecchio L.E., Ainora M.E., Gasbarrini A., Scaldaferri F., Zocco M.A. "Role of Multiparametric Intestinal Ultrasound in the Evaluation of Response to Biologic Therapy in Adults with Crohn's Disease." Diagnostics (MDPI). 2022 yil 17 avgust. Vol. 12, No. 8, Article 1991. DOI:
10.3390/diagnostics12081991. PMCID: PMC9407413. Mualliflar: Rim, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Italiya.
(3) Taylor S.A., Mallett S., Bhatnagar G. va boshq. "Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trial." The Lancet Gastroenterology & Hepatology. 2018 yil 15 iyun. Vol. 3, pp. 548–558. 284 bemor, 8 ta UK kasalxonasi. DOI: 10.1016/S2468-1253(18)30161-4. PMCID: PMC6278907.
(4) Maaser C., Sturm A., Vavricka S.R. va boshq. (ECCO va ESGAR nomidan). "ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications." Journal of Crohn's and Colitis. 2019 yil 1 fevral. Vol. 13, No. 2, pp. 144–164. DOI: 10.1093/ecco-jcc/jjy113. PubMed PMID: 30137275.
(5) Lovett G.C., Schulberg J.D., Hamilton A.L., Wilding H.E., Kamm M.A., Wright E.K. "Intestinal Ultrasound and MRI for Monitoring Therapeutic Response in Luminal Crohn's Disease: A Systematic Review." Journal of the American College of Radiology (JACR). 2024 yil mart. Vol. 21, No. 3, pp. 441–463. 24 tadqiqot, 5760 ta yozuv. DOI: 10.1016/j.jacr.2023.09.010.
PubMed PMID: 37852561.
(6) Ordás I., Rimola J., García-Bosch O. va boshq. "Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn's Disease." Gastroenterology. 2019 yil aprel. Vol. 157, No. 2, pp. 432–439. DOI: 10.1053/j.gastro.2019.04.017. PubMed PMID: 30953614. Mualliflar: Barcelona, Hospital Clínic de Barcelona.
(7) Lafeuille P., Hordonneau C., Vignette J. va boshq. "Transmural healing and MRI healing are associated with lower risk of bowel damage progression than endoscopic mucosal healing in Crohn's disease." Alimentary Pharmacology & Therapeutics. 2021 yil. Vol. 53, No. 5, pp. 577–586. 154 bemor. DOI: 10.1111/apt.16232. PubMed PMID: 33368525.
(8) Geyl S., Guillo L., Laurent V., D'Amico F., Danese S., Peyrin-Biroulet L. "Transmural healing as a therapeutic goal in Crohn's disease: a systematic review." The Lancet Gastroenterology & Hepatology. 2021 yil avgust. Vol. 6, No. 8, pp. 659–667. 17 ta tadqiqot. DOI: 10.1016/S2468-1253(21)00096-0.
PubMed PMID: 34090579. Mualliflar: Frantsiya, Lorraine universiteti.
(9) Hamilton A.L. va boshq. "Accuracy of point-of-care intestinal ultrasound for Crohn's disease." Journal of Gastroenterology and Hepatology (JGH Open). 2021. 42 bemor POCUS + MRE. DOI: 10.1002/jgh3.12269. PMCID:
PMC8411776. Mualliflar: St. Vincent's Hospital Melbourne, Avstraliya.
(10) Nardone O.M., Calabrese G., Testa A., Caiazzo A., Fierro G., Rispo A., Castiglione F. "The Impact of Intestinal Ultrasound on the Management of Inflammatory Bowel Disease: From Established Facts Toward New Horizons." Frontiers in Medicine. 2022 yil 23 may. Vol. 9, Article 898092. DOI: 10.3389/fmed.2022.898092. PMCID: PMC9167952. Mualliflar: Naples Frederick II universiteti, Italiya.
(11) Al-Bawardy B. va boshq. "The role of MRI in perianal fistulizing disease: diagnostic imaging and classification systems to monitor disease activity." Frontiers in Medicine. 2025 yil yanvar. DOI: 10.3389/fmed.2025.1540869. PMCID: PMC11794340.
12.(12) Pruijt M.J., De Voogd F.A.E., Montazeri N.S.M. va boshq. "Diagnostic Accuracy of Intestinal Ultrasound in the Detection of Intra-Abdominal Complications in Crohn's Disease: A Systematic Review and Meta-Analysis." Journal of Crohn's and Colitis. 2024 yil 4 yanvar. Vol. 18, No. 6, pp. 958–972. DOI: 10.1093/ecco-jcc/jjad215. PMCID: PMC11147796. Mualliflar: Amsterdam UMC, Niderlandiya.
13. (13) Kucharzik T., Wilkens R., D'Agostino M.A. va boshq. "Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn's Disease." Clinical Gastroenterology and Hepatology. 2023 yil yanvar. Vol. 21, No. 1, pp. 153–163. DOI:
10.1016/j.cgh.2022.05.055. PubMed PMID: 35671864. Birinchi xalqaro ko'p markazli intervension UTT tadqiqoti.
14.(14) Kumar S., De Kock I., Blad W., Hare R., Pollok R., Taylor S.A. "ESR Essentials: diagnosis and assessment of treatment response in patients with luminal Crohn's disease — practice recommendations by the European Society of Gastrointestinal and Abdominal Radiology." European Radiology. 2025 yil 11 iyun. DOI: 10.1007/s00330-025-11620-2. PMCID:
PMC12634764. Mualliflar: University College London va boshqa Yevropa markazlari.
15.(15) Kucharzik T. va boshq. (ECCO, ESGAR, ESP, IBUS nomidan). "ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1." Journal of Crohn's and Colitis. 2025 yil 3 iyul. Vol. 19, No. 7, Article jjaf106. DOI: 10.1093/ecco-jcc/jjaf106. PubMed PMID: 40741688. To'liq xalqaro konsensus
